One of Monte Rosa Therapeutics' main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders. This process also leverages AI. They now have two important partnerships with Roche and Novartis, which I think validate its technology to some extent, but have also given it non-dilutive funding. Currently, its pipeline has MRT‑2359, MRT‑6160, and MRT‑8102, with key data expected in 2025.
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app, Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), is proud to announce the launch of its Safety Academy, a transformative initiative designed to enhance rider safety and promote a culture of responsible and sustainable mobility practices. The Marti Safety Academy provides riders with the knowledge and tools to promote the safe and responsible use of its two-wheeled electric vehicle solutions. The program in.
Marti Technologies, Inc. is a "Strong Buy" in Turkey's ride-hailing market, trading at $3.54 per share with a $207 million market cap. Experienced founders, leading market position, and recent monetization of ride-hailing services highlight Marti's competitive advantages and growth potential. Financial outlook for 2025 shows significant revenue growth, positive EBITDA, and free cash flow, driven by expanded services and operational efficiencies.
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app, Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT) today announced the launch of its dynamic pricing model, designed to improve service efficiency and enhance user satisfaction in its ride-hailing service. This innovative pricing strategy adjusts ride-hailing fares in real-time based on supply and demand, ensuring that riders receive timely service while helping drivers maximize their earnings. The launch of.
Marti surpassed 1.6 million riders and 255,000 drivers, achieving 15% ride growth in six months. Estimated at $9–$12 billion TAM, with Marti positioned to capture a $2 billion revenue potential. Marti's driver subscription model implies a 10% effective take rate, offering $800 million initial revenue potential.
ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye's leading mobility super app, today announced the election of Alex Spiro to its Board of Directors as a Class II director at the Company's 2024 annual general meeting of shareholders. In addition to being a well known litigator and partner at Quinn Emanuel Urquhart & Sullivan LLP, Mr. Spiro serves as Chairman of Glassbridge Enterprises and is a board member and strategic advisor to a.
ISTANBUL--(BUSINESS WIRE)--Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye's leading mobility super app, announced today that as of December 15, 2024, Marti's ride-hailing service has reached 1.61 million riders and 255 thousand registered drivers, exceeding the December 31, 2024 targets of 1.60 million riders and 245 thousand registered drivers. Marti's number of ride-hailing riders grew 15% from September 30, 2024 to December 15, 2024. The number of registere.
Results from dose escalation arms of Phase 1/2 study of MRT-2359 demonstrated a favorable safety profile and targeted levels of GSPT1 degradation using a 21 days on, 7 days off drug dosing schedule in heavily pretreated solid tumor patients Recommended Phase 2 dose determined as 0.5 mg daily at a 21 days on, 7 days off drug dosing schedule Additional MRT-2359 Phase 1/2 study clinical results, including biomarker and activity data, anticipated in Q1 2025 BOSTON, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today reported an update from its ongoing Phase 1/2 open-label, multicenter study of MRT-2359 in patients with MYC-driven solid tumors. MRT-2359 is an investigational, orally bioavailable, GSPT1-directed MGD discovered and developed by Monte Rosa Therapeutics.
ISTANBUL--(BUSINESS WIRE)--Türkiye's leading mobility super app, Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT) announces its expectation to reach positive free cash flow in 2025 and presents 2025 guidance. After two years of investing in growing its ride-hailing business, Marti announced in October 2024 that it has begun monetizing its ride-hailing service. As the only at scale ride-hailing operator in the country, together with the monetization of its ride-hailing se.
SINGAPORE, Nov. 22, 2024 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management sector, through its subsidiary, today announced that the Company had completed the sale and successful deployment of 89 autonomous cleaning robots across Singapore, marking the largest robotic fleet in the land transport sector with rail operator SMRT Trains.